This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wednesday's Small-Cap Winners & Losers

Small stocks were mixed Wednesday and largely kept pace with the confused broader market, staying flat to negative for much of the day before climbing into positive territory.

Seattle-based biotech Dendreon (DNDN) was the day's biggest loser overall, and one of the most furiously traded, after the Food and Drug Administration asked for additional clinical data on its prostate-cancer vaccine Provenge before granting approval. Shares plummeted 62% to $6.78.

The Russell 2000, of which Dendreon is a component, was nevertheless higher by 0.4% at 834.41. The S&P SmallCap 600 rose 0.5% to 433.32.

Another small biotech, Curis (CRIS - Get Report), got a black eye after Proctor & Gamble (PG) decided to end its collaboration with the Cambridge, Mass., company, citing an unacceptable safety profile for the hair-growth compounds thus far developed under the agreement. Curis shares plunged 20.5% to $1.47; P&G lately added 0.7% to $62.19.

Oil-and-gas driller Toreador Resources (TRGL) lost 15.1% to $13.13 after swinging to a steep first-quarter loss, largely blamed on a dry exploration well, against Wall Street's upside expectations from Thomson Financial. The Dallas-based company also filed for a $49.2 million shelf offering after the close Tuesday.

Also reporting lower-than-expected first-quarter bottom lines were Illinois-based TreeHouse Foods (THS), recently sliding 9% to $29.07, and Hawaii's Hoku Scientific (HOKU), a clean-energy-technologies developer, giving up 12.2% to $4.43.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
JRCC $0.00 0.00%
BPHX $2.67 -1.48%
CRIS $2.79 0.00%
STXS $1.82 0.00%
TRT $3.03 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs